SCM
DGX icon

Sebold Capital Management’s Quest Diagnostics DGX Stock Holding History

Sebold Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$276K Buy
1,537
+4
+0.3% +$695 0.17% 68
2025
Q1 		$259K Buy
+1,533
New +$252K 0.17% 65
2024
Q4 		– Sell
-1,354
Closed -$210K – 72
2024
Q3 		$210K Buy
+1,354
New +$202K 0.14% 67

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sebold Capital Management's DGX Position: Q2 2025 in Review

Sebold Capital Management increased its Quest Diagnostics (DGX) stake by 0.26% in Q2 2025, buying an estimated $695 and bringing the position to 1,537 shares worth $276K. The position accounts for 0.17% of the portfolio, ranked #68.

Sebold Capital Management first reported a position in DGX in Q3 2024 and has held it in 3 quarters since. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Sebold Capital Management held 1,537 shares of Quest Diagnostics worth $276K as of Q2 2025.
  • Sebold Capital Management bought 4 Quest Diagnostics shares in Q2 2025, an estimated $695.
  • Quest Diagnostics made up 0.17% of Sebold Capital Management's portfolio in Q2 2025, its #68 holding.
  • Sebold Capital Management first reported a position in Quest Diagnostics in Q3 2024 and has held it in 3 quarters since.
  • 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Sebold Capital Management's 13F filing for Q2 2025, filed 5 Aug 2025.